Subscribe To Our Free Newsletter |
Lupin receives USFDA approval for Dronedarone Tablets
Dronedarone Tablets USP, 400 mg, are indicated to reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of paroxysmal or persistent AF.